Publikationen

(Auszug)

|
The effects of strength and endurance training in patients with rheumatoid arthritis.
Strasser B, Leeb G, Strehblow C, Schobersberger W, Haber P, Cauza E.
Clin Rheumatol. 2011 May;30(5):623-32.

|
Effects of progressive strength training on muscle mass in type 2 diabetes mellitus patients determined by computed tomography.
Cauza E, Strehblow C, Metz-Schimmerl S, Strasser B, Hanusch-Enserer U, Kostner K, Dunstan D, Fasching P, Haber P.
Wien Med Wochenschr. 2009;159(5-6):141-7.

|
The benefit of strength training on arterial blood pressure in patients with type 2 diabetes mellitus measured with ambulatory 24-hour blood pressure systems.
Strasser B, Haber P, Strehblow C, Cauza E.
Wien Med Wochenschr. 2008;158(13-14):379-84.

|
Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.
Hanusch-Enserer U, Ghatei MA, Cauza E, Bloom SR, Prager R, Roden M.
Wien Klin Wochenschr. 2007;119(9-10):291-6.

|
Vascular endothelial growth factor in patients with psoriatic arthritis.
Fink AM, Cauza E, Hassfeld W, Dunky A, Bayer PM, Jurecka W, Steiner A.
Clin Exp Rheumatol. 2007 Mar-Apr;25(2):305-8.

|
[Psoriatic arthritis].
Cauza E, Dunky A.
Wien Med Wochenschr. 2006 Nov;156(21-22):587-95.

|
The metabolic effects of long term exercise in Type 2 Diabetes patients.
Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P.
Wien Med Wochenschr. 2006 Sep;156(17-18):515-9.

|
Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.
Cauza E, Hanusch-Enserer U, Frischmuth K, Fabian B, Dunky A, Kostner K.
J Clin Pharm Ther. 2006 Apr;31(2):149-52.

|
Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system.
Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P.
Eur J Clin Invest. 2005 Dec;35(12):745-51.

|
HDL therapy: the next big step in the treatment of atherosclerosis?
Kostner KM, Cauza E.
Future Cardiol. 2005 Nov;1(6):767-73. doi: 10.2217/14796678.1.6.767.

|
Continuous glucose monitoring in diabetic long distance runners.
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Kostner K, Dunky A, Haber P.
Int J Sports Med. 2005 Nov;26(9):774-80.

|
Increased C282Y heterozygosity in gestational diabetes.
Cauza E, Hanusch-Enserer U, Bischof M, Spak M, Kostner K, Tammaa A, Dunky A, Ferenci P.
Fetal Diagn Ther. 2005 Sep-Oct;20(5):349-54.

|
The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus.
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, Wagner O, Georg P, Prager R, Kostner K, Dunky A, Haber P.
Arch Phys Med Rehabil. 2005 Aug;86(8):1527-33.

|
HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis.
Cauza E, Hanusch-Enserer U, Etemad M, Köller M, Kostner K, Georg P, Dunky A, Ferenci P.
Clin Exp Rheumatol. 2005 Jan-Feb;23(1):7-12.

|
Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
Cauza E, Jansen M, Resch U, Dunky A, Derfler K, Winklhofer-Roob BM, Kostner K.
J Clin Apher. 2004;19(4):174-9.

|
Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
Cauza E, Etemad M, Winkler F, Hanusch-Enserer U, Partsch G, Noske H, Dunky A.
J Clin Pharm Ther. 2004 Oct;29(5):431-6.

|
Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding.
Hanusch-Enserer U, Cauza E, Brabant G, Dunky A, Rosen H, Pacini G, Tüchler H, Prager R, Roden M.
J Clin Endocrinol Metab. 2004 Jul;89(7):3352-8.

|
Improvement of insulin resistance and early atherosclerosis in patients after gastric banding.
Hanusch-Enserer U, Cauza E, Spak M, Endler G, Dunky A, Tura A, Wagner O, Rosen HR, Pacini G, Prager R.
Obes Res. 2004 Feb;12(2):284-91.

|
[Methotrexate therapy in rheumatologic diseases--an update].
Cauza E, Dunky A.
Wien Med Wochenschr. 2003;153(13-14):291-4.

|
Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function.
Cauza E, Kletzmaier J, Bodlaj G, Dunky A, Herrmann W, Kostner K.
Nephrol Dial Transplant. 2003 Aug;18(8):1568-72.

|
Effect of gastric banding on aminoterminal pro-brain natriuretic peptide in the morbidly obese.
Hanusch-Enserer U, Hermann KM, Cauza E, Spak M, Mähr B, Dunky A, Rosen HR, Köller U, Prager R.
Obes Res. 2003 Jun;11(6):695-8.

|
Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K.
Wien Klin Wochenschr. 2002 Dec 30;114(23-24):1004-7.

|
Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding.
Hanusch-Enserer U, Cauza E, Spak M, Dunky A, Rosen HR, Wolf H, Prager R, Eibl MM.
Int J Obes Relat Metab Disord. 2003 Mar;27(3):355-61.

|
Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schöniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Müller C, Wrba F, Gangl A, Ferenci P.
Am J Gastroenterol. 2003 Feb;98(2):442-7.

|
Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.
Cauza E, Spak M, Cauza K, Hanusch-Enserer U, Dunky A, Wagner E.
Rheumatol Int. 2002 Nov;22(6):227-32.

|
Distribution of patients with Wilson disease carrying the H1069Q mutation in Austria.
Cauza E, Ulrich-Pur H, Polli C, Gangl A, Ferenci P.
Wien Klin Wochenschr. 2000 Jul 7;112(13):576-9.

|
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin.
Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P.
J Hepatol. 1997 Aug;27(2):358-62.